Cargando…
How a Psychopharmacology Clinical Trial Site in the Seattle Area Managed Clinical Trials and Patient Care During the COVID-19 Pandemic
OBJECTIVES: As the COVID-19 pandemic developed in March 2020 in greater Seattle, our clinical trial site faced several ethical and clinical dilemmas. We remained open to research patients including high-risk elderly patients and adapted to changing health recommendations. METHODS: Beginning March 14...
Autores principales: | Schilling, Shirin, Mohanarajah, Sinthuja, Mengstu, Abraham, Khan, Arif, Brown, Walter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299855/ https://www.ncbi.nlm.nih.gov/pubmed/32680760 http://dx.doi.org/10.1016/j.jagp.2020.06.012 |
Ejemplares similares
-
A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials
por: Coates, Margaret, et al.
Publicado: (2018) -
Special section on psychopharmacology trials in children and adolescents
por: Fegert, Joerg M
Publicado: (2008) -
The Impact of Psychopharmacology on Contemporary Clinical Psychiatry
por: Vázquez, Gustavo H
Publicado: (2014) -
Risk factors for major bleeding in the SEATTLE II trial
por: Sadiq, Immad, et al.
Publicado: (2017) -
Psychopharmacology
Publicado: (1989)